Skip to main content
Caplight Logo









DisperseBio

DisperseBio

Private
Tel AvivFrontier & Industrial Techhttps://www.dispersebio.com/

Last Round

Accelerator

Mar 21, 2025

Total Funding Raised

$475,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DisperseBio is a biotechnology company that develops synthetic, biomimetic peptides designed to prevent biofouling on engineered surfaces.

Sector

Frontier & Industrial Tech

Verticals

Water Treatment, Maritime & Shipping, Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biofouling controlantifouling coatingsynthetic peptidesbiofilm preventionnon-toxic antifoulingfoul-release coatingbiomimetic technologyeco-friendly antifoulingwater treatmentdesalinationmaritime antifoulingdrop-in treatmentpeptide technologysustainable materialsindustrial water cooling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DisperseBio Comparables

Compare DisperseBio with similar companies based on industry and business-model similarity.

DisperseBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Repela Tech
77%
I-Tech AB
61%
Pure Blue Tech
59%

DisperseBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 21, 2025
Pre SeedApr 1, 2023

Key People

Founding team and executive leadership

Amir Zlotkin

Founder & CTO

Founding Team

DisperseBio Investors

Notable investors and investment history

DisperseBio investors
InvestorRounds
Israeli National Center of Blue EconomyPre Seed, Accelerator
IndieBioAccelerator
HiCenterPre Seed, Accelerator
SOSVAccelerator
Twynam Funds ManagementAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors grew 158% MoM, reaching 1K.

  • Mar 21, 2025

    $275K raised from SOSV and Twynam Funds Management.

DisperseBio Filings

Explore SEC and related filing metadata, where available.

DisperseBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DisperseBio's valuation, stock price, and market status.

Is DisperseBio a public or private company?

DisperseBio is a private company.

What is the current stock price of DisperseBio?

DisperseBio is a private company with no public stock price. No recent secondary market data is available.

How much is DisperseBio worth (valuation)?

Valuation information for DisperseBio is not publicly available.

Can I buy DisperseBio stock?

DisperseBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DisperseBio's last funding round?

DisperseBio's most recent funding round was Accelerator on March 21, 2025.

Who are the main investors in DisperseBio?

Key investors in DisperseBio include Israeli National Center of Blue Economy, IndieBio, HiCenter, SOSV, Twynam Funds Management.

Will DisperseBio IPO soon?

No public IPO plans have been announced for DisperseBio.

How can I track DisperseBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DisperseBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range4
Year Founded2021
Last FundingMar 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?